A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Pancreatic Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Wenming Wu, MD)Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Principal Investigator (Zhihua Li, MD)Union Hospital Tongji Medical College Huazhong University of Science And Technology, Wuhan, Hubei, China
Contact: Principal Investigator (Heshui Wu, MD)Shandong Cancer Hospital, Jinan, Shandong, China
Contact: Principal Investigator (He Tian, MD)Shanghai Changhai Hospital, Shanghai, Shanghai Municipality, China
Contact: Principal Investigator (Gang Jin, MD)Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Contact: Principal Investigator (Qi Xu, MD)Zhejiang Provincial People's hospital, Hangzhou, Zhejiang, China
Contact: Principal Investigator (Yiping Mou, MD)